KALY — Kali Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$29.41m
- $94.55m
Brief: Pura Explores Acquisition Of Kaly CBD Confection Assets
Brief: Kaly Confirms Consolidation Plans To Focus On $50 Bln Cannabis Biopharmaceutical Market Opportunity
Brief: Kali-Extracts Plans To Certify CBD Extract As OTC Drug Under FDA Requirements
Brief: Kali Says Co Receives Proposal To Certify Its CBD Extract As OTC Drug Under FDA Requirements
Brief: Kali Extracts Files Patent Application For CBD Formulation
Brief: KALY Considers Increasing 2019 $20 Million CBD Extraction Revenue Target
Brief: Kali Announces Hemp Derived CBD Extraction Contract Worth $10 Mln In Annual Revenue With Nouveau Inc
Brief: USMJ And Kaly Plan Meatless CBD Infused Burgers For Partnership With WCVC
Brief: Kaly Targets $20 Million In Cbd Extraction This Year
Brief: Kaly Initiates Phase Two Cannabis Extract COPD Treatment Study
Brief: Kali engages Caprock Research to initiate independent analyst coverage